Advertisement
Policy Forum

Policy Forum Policy Forum articles provide a platform for health policy makers from around the world to discuss the challenges and opportunities in improving health care to their constituencies.

See all article types »

Being More Realistic about the Public Health Impact of Genomic Medicine

  • Wayne D. Hall mail,

    w.hall@uq.edu.au

    Affiliations: University of Queensland Centre for Clinical Research, The University of Queensland, Herston, Queensland, Australia, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia

    X
  • Rebecca Mathews,

    Affiliation: University of Queensland Centre for Clinical Research, The University of Queensland, Herston, Queensland, Australia

    X
  • Katherine I. Morley

    Affiliations: Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, The University of Melbourne, Victoria, Australia

    X
  • Published: October 12, 2010
  • DOI: 10.1371/journal.pmed.1000347

Reader Comments (1)

Post a new comment on this article

Must be read by public and private managers allocating drug R&D resources

Posted by ManuelD on 18 Jan 2011 at 00:30 GMT

Patients, health practitioners and medical researchers greatly benefit and will benefit from the progress of genomic. However, as very well stated by the authors of this Column entitled "Being More Realistic about the Public Health Impact of Genomic Medicine", it is also critical to assess the real impact of genetic and genomic in public health. Such that the other areas of medical research receive the support they deserve.

Competing interests declared: I am a research scientist in a Drug R&D private organization.